Dopamine in Neonate

Seoul National University

Status and phase: Unknown; Phase 2

Conditions: Neonates and Preterm Infants

Treatments: Drug: Dopamine

Study type: Interventional

Funder types: Other

Identifiers

NCT04525495

DPMSNUH

Details and patient eligibility

About

The purpose of this study is to investigate the pharmacokinetics and pharmacodynamics of dopamine which is used as treatment of hypotension in neonate and preterm infant.

Enrollment: 30 estimated patients

Sex: All

Ages: Under 1 month old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Admitted at NICU in Seoul National University Hospital, Seoul Asan Hospital or Severance Hospital
• Infants who were diagnosed with hypotension

Exclusion criteria

• Congenital heart disease
• Chromosomal anomaly
• Treated with ECMO or CRRT
• Arrhythmia
• Hypovolemic state

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

30 participants in 1 patient group

Dopamine treatment

Experimental group

Treatment:

Drug: Dopamine